Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and ope...
Core One Labs reported revenue of 648,088 CAD for fiscal year 2023, up 50.2% from fiscal year 2022, and net income of -15.98 million CAD. In Q3 2024 (the quarter ended December 31, 2023) revenue was 93,661 CAD, down 64.9% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2022.
No profile data available.